| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2023 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 49.2k | $3.92 | $193k | | 06/15/2023 |
| 06/15/2023 | ARDELYX, INC. | ARDX | Grant | Common Stock | 16.6k | $0.00 | $0 | | 06/15/2023 |
| 01/12/2023 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 5k | $1.71 | $8.5k | | 01/11/2023 |
| 01/11/2023 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 3.8k | $1.75 | $6.7k | | 01/11/2023 |
| 01/04/2023 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 3.6k | $1.69 | $6.1k | | 01/04/2023 |
| 06/15/2022 | ARDELYX, INC. | ARDX | Grant | Common Stock | 118.6k | $0.00 | $0 | | 06/15/2022 |
| 06/15/2022 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 100k | $0.55 | $54.8k | | 06/15/2022 |
| 01/18/2022 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 4.4k | $3.19 | $13.9k | | 01/18/2022 |
| 01/12/2022 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 1.4M | $0.00 | $0 | | 01/12/2022 |
| 01/12/2022 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 314.3k | $0.00 | $0 | | 01/12/2022 |
| 01/12/2022 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 2.2k | $3.54 | $8k | | 01/11/2022 |
| 01/11/2022 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 3.8k | $3.56 | $13.4k | | 01/11/2022 |
| 01/04/2022 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 3.5k | $4.06 | $14.2k | | 01/04/2022 |
| 07/02/2021 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 4.4k | $4.26 | $18.7k | | 07/02/2021 |
| 06/16/2021 | ARDELYX, INC. | ARDX | Grant | Common Stock | 8.9k | $0.00 | $0 | | 06/16/2021 |
| 06/16/2021 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 32.8k | $7.31 | $239.5k | | 06/16/2021 |
| 01/12/2021 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 2.2k | $6.15 | $13.7k | | 01/12/2021 |
| 01/11/2021 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 1.1M | $0.00 | $0 | | 01/11/2021 |
| 01/11/2021 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 242.7k | $0.00 | $0 | | 01/11/2021 |
| 01/04/2021 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 3.5k | $5.33 | $18.6k | | 01/04/2021 |
| 12/14/2020 | Adaptimmune Therapeutics PLC | ADAP | Purchase | | 207k | $0.69 | $143.8k | | 12/14/2020 |
| 12/14/2020 | ARDELYX, INC. | ARDX | Grant | Common Stock | 15k | $7.08 | $106.3k | | 12/14/2020 |
| 06/09/2020 | ARDELYX, INC. | ARDX | Grant | Common Stock | 7.5k | $0.00 | $0 | | 06/09/2020 |
| 06/09/2020 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 23.5k | $7.31 | $171.8k | | 06/09/2020 |
| 01/16/2020 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 1.3M | $0.00 | $0 | | 01/16/2020 |
| 01/16/2020 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 280.9k | $0.00 | $0 | | 01/16/2020 |
| 01/14/2020 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 2.4k | $5.13 | $12.3k | | 01/14/2020 |
| 01/06/2020 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 3.7k | $1.20 | $4.5k | | 01/06/2020 |
| 06/13/2019 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 50k | $2.74 | $137k | | 06/13/2019 |
| 06/13/2019 | ARDELYX, INC. | ARDX | Grant | Common Stock | 18.2k | $0.00 | $0 | | 06/13/2019 |
| 01/14/2019 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 2.3k | $5.37 | $12.2k | | 01/14/2019 |
| 01/04/2019 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 224.7k | $0.00 | $0 | | 01/04/2019 |
| 01/04/2019 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 1M | $0.00 | $0 | | 01/04/2019 |
| 06/13/2018 | ARDELYX, INC. | ARDX | Grant | Common Stock | 12.4k | $0.00 | $0 | | 06/13/2018 |
| 06/13/2018 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 15k | $4.03 | $60.4k | | 06/13/2018 |
|